The neural basis of psychedelic action.
Alex C KwanDavid E OlsonKatrin H PrellerBryan L RothPublished in: Nature neuroscience (2022)
Psychedelics are serotonin 2A receptor agonists that can lead to profound changes in perception, cognition and mood. In this review, we focus on the basic neurobiology underlying the action of psychedelic drugs. We first discuss chemistry, highlighting the diversity of psychoactive molecules and the principles that govern their potency and pharmacokinetics. We describe the roles of serotonin receptors and their downstream molecular signaling pathways, emphasizing key elements for drug discovery. We consider the impact of psychedelics on neuronal spiking dynamics in several cortical and subcortical regions, along with transcriptional changes and sustained effects on structural plasticity. Finally, we summarize neuroimaging results that pinpoint effects on association cortices and thalamocortical functional connectivity, which inform current theories of psychedelic action. By synthesizing knowledge across the chemical, molecular, neuronal, and network levels, we hope to provide an integrative perspective on the neural mechanisms responsible for the acute and enduring effects of psychedelics on behavior.
Keyphrases
- drug discovery
- functional connectivity
- resting state
- signaling pathway
- white matter
- healthcare
- liver failure
- bipolar disorder
- gene expression
- drug induced
- transcription factor
- cerebral ischemia
- single molecule
- mild cognitive impairment
- respiratory failure
- network analysis
- intensive care unit
- depressive symptoms
- epithelial mesenchymal transition
- brain injury
- subarachnoid hemorrhage
- pi k akt
- cell proliferation
- induced apoptosis
- heat shock protein